Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› San Luis Potosí City
Clinical trial register · Mexico

Clinical Trials in San Luis Potosí City, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Mexico and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1585 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:19 UTC
1585
Studies in scope
all four open statuses
704
Recruiting now
open to new participants
247
Lead sponsors
across recruiting studies
Top sites
Mexico City 600 Monterrey 378 Guadalajara 344 Chihuahua City 177 Mérida 128

Trials with a site in San Luis Potosí City

74 of 1585 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Mexico
Start
Recruiting
AstraZeneca
Phase 3
1,072
Guadalajara, México, San Luis Potosí City, Veracruz
2026-08-31
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Guadalajara, México, Monterrey, Querétaro, San Luis Potosí City, Tijuana, Xalapa, Zapopan
2026-08-24
Recruiting
AstraZeneca
Phase 3
2,000
Cuernavaca, Guadalajara, Monterrey, San Luis Potosí City, Zapopan
2026-07-06
Recruiting
Bayer
Phase 3
117
Guadalajara, México D.F., Tlalpan, Monterrey, Huixquilucan, Ciudad Madero, Querétaro, San Luis Potosí City
2026-06-01
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Guadalajara, Léon, San Luis Potosí City, San Pedro Garza García
2026-05-23
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aguascalientes, Cuernavaca, San Luis Potosí City, Culiacan Sinaloa, Distrito Federal
2026-05-11
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Chihuahua City, Mexicali, Mexico City, Mérida, Querétaro, San Luis Potosí City
2026-03-05
Recruiting
Universidad Autonoma de San Luis Potosí
Not applicable
60
San Luis Potosí City
2026-03-02
Recruiting
Neuromuscular Variables and Performance in Mexican Weightlifters
NCT07277335Isometric Muscle Strength, Jumping Performance, Weightlifting, Performance Measures
Ángel Rodríguez
Observational
50
San Luis Potosí City
2025-12-27
Recruiting
Bristol-Myers Squibb
Phase 3
650
Saltillo, Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Tlalnepantla
2025-12-02
Recruiting
Bayer
Phase 3
111
Guadalajara, Mexico City, Monterrey, Querétaro City, San Luis Potosí City, Huixquilucan, Ciudad Madero, Tlalpan
2025-11-19
Active, closed
Hoffmann-La Roche
Phase 2
193
Mexico City, San Luis Potosí City, Culiacán
2025-11-13
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Chihuahua City, Benito Juárez, Mexico City, San Luis Potosí City
2025-11-11
Recruiting
BioNTech SE
Phase 3
558
Aguascalientes, León, Mexico City, Monterrey, San Luis Potosí City, Zapopan
2025-10-30
Recruiting
Pfizer
Phase 2/3
982
Guadalajara, Oaxaca City, San Luis Potosí City
2025-10-03
Recruiting
Genentech, Inc.
Phase 2
224
Guadalajara, Tlajomulco de Zúñiga, Mérida, San Luis Potosí City, Veracruz
2025-09-29
Recruiting
Bristol-Myers Squibb
Phase 3
426
Saltillo, Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Tlalnepantla
2025-07-10
Recruiting
AstraZeneca
Phase 3
5,000
Chihuahua City, Cuauhtémoc, D.F, Durango, Guadalajara, Mazatlán, Mérida, San Luis Potosí City
2025-03-03
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Culiacán, Guadalajara, Mexicali, Mexico City, Monterrey, San Luis Potosí City
2025-01-09
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Culiacán, Guadalajara, Mexico City, Mexico D F, Mérida, México, Querétaro, San Luis Potosí City
2024-12-04
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Monterrey, San Luis Potosí City
2024-10-24
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Guadalajara, México, Querétaro, San Luis Potosí City
2024-10-07
By invitation
Viatris Innovation GmbH
Phase 3
680
León, Mérida, San Luis Potosí City, Zapopan
2024-07-30
Active, closed
GlaxoSmithKline
Phase 3
88
Guadajalara, La Paz BCS, Mexico City, San Luis Potosí City
2024-06-10
Active, closed
GlaxoSmithKline
Phase 4
302
Cuauhtémoc, DF, Guadalajara Jalisco, León, Mexico City, Mérida, Monterrey Nuevo LeOn, San Luis Potosí City
2024-06-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
473
Guadalajara, Mexico City, Monterrey, Oaxaca City, San Luis Potosí City
2024-05-03
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Monterrey, Culiacán, Coahuila, Estado de México, San Luis Potosí City
2024-04-23
Recruiting
Proteinopathies Expression in Skin of Neurodegenerative Disorders
NCT06528964Alzheimer Disease, Frontotemporal Dementia, Parkinson Disease, Atypical Parkinsonism
Universidad Autonoma de San Luis Potosí
Observational
40
San Luis Potosí City
2023-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Oaxaca City, Puebla City
2023-12-15
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Pharmaceuticals, Inc.
Phase 3
510
Guadalajara, Mexico City, Puebla City, San Luis Potosí City, Monterrey, Oaxaca City, Sinaloa
2023-11-16
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Monterrey, Coahuila, Estado de México, Mazatlán, Mexico City, Nuevo León, San Luis Potosí City, Sinaloa
2023-11-14
Active, closed
AstraZeneca
Phase 3
314
Chihuahua City, Guadalajara, Mexico City, San Luis Potosí City
2023-11-08
Active, closed
Amgen
Phase 3
633
León, Guadalajra, Mexico City, Monterrey, San Pedro Garza García, Juchitán de Zaragoza, San Luis Potosí City, Culiacán
2023-11-02
Active, closed
AstraZeneca
Phase 3
5,511
Alc. Cuauhtémoc, Mérida, San Luis Potosí City, Tuxtla Gutiérrez, Veracruz
2023-10-05
Recruiting
AstraZeneca
Phase 3
4,300
Aguascalientes, Alc. Cuauhtémoc, Colonia Lindavista, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Mexico City, Mérida, Monterrey, San Luis Potosí City
2023-03-23
Active, closed
Insmed Incorporated
Phase 2/3
91
Lomas de Guevara, Monterrey, Mexico City, San Luis Potosí City
2023-03-07
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Guadalajara, Cuernavaca, Monterrey, San Luis Potosí City, Culiacán, Ciudad Madero, Xalapa, Aguascalientes
2023-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Aguascalientes, Distrito Federal, Mexico City, Morelia, San Luis Potosí City
2023-02-15
Active, closed
Zenas BioPharma (USA), LLC
Phase 3
194
Mexico City, San Luis Potosí City
2023-01-09
Active, closed
AstraZeneca
Phase 3
1,350
Del. Cuauhtemoc, Mexico City, México, San Luis Potosí City
2022-12-29
Recruiting
AstraZeneca
Phase 3
3,527
Aguascalientes, Guadalajara, Mexico City, Monterrey, San Luis Potosí City, Tlalpan, Xalapa
2022-12-13
Active, closed
Viatris Innovation GmbH
Phase 3
470
Guadalajara, León, Mexico City, Mérida, Morelia, Querétaro, San Luis Potosí City, Zapopan
2022-12-13
Active, closed
GlaxoSmithKline
Phase 2
351
Guadajalara, San Luis Potosí City
2022-10-14
Active, closed
Gilead Sciences
Phase 3
443
Chihuahua City, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2022-07-25
Active, closed
Gilead Sciences
Phase 3
623
Chihuahua City, Culiacán, Guadalajara, Mexico City, Mérida, México, Monterrey, San Luis Potosí City
2022-07-20
Active, closed
Hoffmann-La Roche
Phase 3
922
La Paz, Guadalajara, D.F., Mexico City, Monterrey, Querétaro City, San Luis Potosí City, Chihuahua City
2022-07-18
Active, closed
AstraZeneca
Phase 3
760
Guadalajara, Jalisco, México, San Luis Potosí City, Tuxtla Gutiérrez
2022-03-28
Active, closed
Eli Lilly and Company
Phase 3
368
Mexicali, Tijuana, Guadalajara, Monterrey, San Luis Potosí City
2022-03-11
Active, closed
Daiichi Sankyo
Phase 3
740
Cuauhtémoc, Guadalajara, Monterrey, Oaxaca City, San Luis Potosí City
2022-03-04
Active, closed
AstraZeneca
Phase 3
363
Chihuahua City, Guadalajara, México, San Luis Potosí City
2022-02-15
By invitation
Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery
NCT05315596Pain, Postoperative, Adult, Pain Measurement, Functional Status
Jena University Hospital
Observational
1,000
El Bajo, León, Mexico City, Guadalajara, Puebla City, San Luis Potosí City
2022-02-01
Active, closed
Bristol-Myers Squibb
Phase 3
670
Saltillo, Guadalajara, Mexico City, San Luis Potosí City, Mérida, Chihuahua City, Veracruz
2021-07-13
Active, closed
Bristol-Myers Squibb
Phase 3
681
Torreón, Tlalpan, Monterrey, Querétaro City, San Luis Potosí City
2021-05-21
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Guadalajara, Juchitán de Zaragoza, León, Mexico City, Monterrey, Morelia, Oaxaca City, San Luis Potosí City
2020-12-07
Active, closed
Hoffmann-La Roche
Phase 3
769
Guadalajara, Mexico City, San Luis Potosí City, México
2020-12-03
Active, closed
Exelixis
Phase 3
575
Tuxtla Gutiérrez, León, Guadalajara, Zapopan, Mexico City, Monterrey, Querétaro City, San Luis Potosí City
2020-10-19
Active, closed
Hoffmann-La Roche
Phase 3
992
CD Mexico, Mexico City, Monterrey, Oaxaca City, San Luis Potosí City, Morelia, Veracruz
2020-10-09
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
CanariaBio Inc.
Phase 3
615
Orizaba, La Paz, Monterrey, Querétaro, San Luis Potosí City
2020-08-25
Active, closed
Eli Lilly and Company
Phase 3
996
Chihuahua City, Monterrey, San Luis Potosí City
2020-06-22
Active, closed
AstraZeneca
Phase 3
805
Aguascalientes, México, Monterrey, Oaxaca City, Querétaro, San Luis Potosí City, Veracruz
2020-05-05
Active, closed
Eli Lilly and Company
Phase 3
261
Mexico City, Guadalajara, San Luis Potosí City
2020-02-17
Active, closed
GlaxoSmithKline
Phase 2
25
San Luis Potosí City
2019-11-28
Recruiting
Gedeon Richter Plc.
Phase 3
330
Culiacán, Durango, Guadalajara, Guanajuato City, Mérida, Monterrey, San Luis Potosí City
2019-06-06
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Distrito Federal, San Luis Potosí City, Veracruz
2019-03-15
Active, closed
AstraZeneca
Phase 2
401
Chihuahua City, Culiacán, San Luis Potosí City
2018-12-21
Active, closed
AstraZeneca
Phase 3
407
Culiacán, Mexico City, México, Monterrey, San Luis Potosí City
2018-11-27
Active, closed
Exelixis
Phase 3
187
Tuxtla Gutiérrez, Ciudad de Mèxico, Mexico City, San Luis Potosí City
2018-10-05
Active, closed
Exelixis
Phase 3
837
Tuxtla Gutiérrez, León, Monterrey, Mexico City, San Luis Potosí City, Veracruz
2018-06-10
Active, closed
Bristol-Myers Squibb
Phase 3
545
Cuauhtémoc, Monterrey, San Luis Potosí City
2018-04-18
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Tijuana, Mexico City, Monterrey, San Luis Potosí City
2017-09-22
Active, closed
Eli Lilly and Company
Phase 2
309
Mexico City, San Luis Potosí City
2016-05-19
Rows per page Showing 1–74 of 74
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Mexican investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-mexico/city/san-luis-potos-city

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Mexico and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,585 studies in total at the last sync on 14 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 74 of those studies with a site in San Luis Potosí City.

How many clinical trials are recruiting in San Luis Potosí City?

24 of the 74 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 47 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (San Luis Potosí City), 74 studies
PhaseStudiesRecruitingShare
Phase 3571777%
Phase 2719.5%
Phase 2/3425.4%
Observational324.1%
Not applicable111.4%
Phase 1/2111.4%
Phase 4101.4%

Most active sponsors

Lead sponsors with the most studies (San Luis Potosí City)
Lead sponsorStudiesRecruiting
AstraZeneca146
Bristol-Myers Squibb73
Janssen Research & Development, LLC72
Hoffmann-La Roche50
Eli Lilly and Company40
GlaxoSmithKline40
Exelixis30
Merck Sharp & Dohme LLC31
Novartis Pharmaceuticals32
ACADIA Pharmaceuticals Inc.21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.